An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate-specific membrane antigen small molecule derivatives.

Contrast media & molecular imaging

Volumn 1, Issue 5, 2006, Pages 196-211

  Humblet, Valerie ^a   Misra, Preeti ^a   Frangioni, John V ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; CONTRAST MEDIUM; GADOLINIUM; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL; LANTHANUM; MEMBRANE ANTIGEN; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS; YTTERBIUM;

ARTICLE; CELL SURVIVAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MALE; MASS SPECTROMETRY; METHODOLOGY; SYNTHESIS; TUMOR CELL LINE;

ANTIGENS, SURFACE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTRAST MEDIA; GADOLINIUM; GLUTAMATE CARBOXYPEPTIDASE II; GLYCOSYLPHOSPHATIDYLINOSITOLS; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; LANTHANUM; MALE; MASS SPECTROMETRY; RADIOPHARMACEUTICALS; YTTERBIUM;

EID: 34547812505     PISSN: None     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.106     Document Type: Article

References (0)